Bay State Times
SEE OTHER BRANDS

The latest news from Massachusetts

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Bay State Times.

Toll Brothers Announces New Luxury Home Community Coming Soon to Briggs Ranch in San Antonio, Texas

Toll Brothers Announces New Luxury Home Community Coming Soon to Briggs Ranch in San Antonio, Texas

SAN ANTONIO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest community, Toll Brothers at Briggs Ranch, is coming soon to San Antonio, Texas. This exclusive...

Quesito El Establo Retira Del Mercado Queso (Quesito Colombiano) Debido a Posible Riesgo Para La Salud

Quesito El Establo Retira Del Mercado Queso (Quesito Colombiano) Debido a Posible Riesgo Para La Salud

COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos...

Toll Brothers Announces Final Opportunity to Own a New Luxury Home at Parklynn Hills Community in Fountain Inn, South Carolina

Toll Brothers Announces Final Opportunity to Own a New Luxury Home at Parklynn Hills Community in Fountain Inn, South Carolina

FOUNTAIN INN, S.C., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the final opportunity to purchase a new Greenville-area home in its Parklynn Hills community in...

Quesito El Establo Retira Del Mercado Queso (Quesito Colombiano) Debido a Posible Riesgo Para La Salud

Quesito El Establo Retira Del Mercado Queso (Quesito Colombiano) Debido a Posible Riesgo Para La Salud

COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos...

Choate Names Rob Kole as Co-Managing Partner

Choate Names Rob Kole as Co-Managing Partner

Choate Hall & Stewart LLP announces that Rob Kole has been named co-managing partner of the firm. BOSTON, MA, UNITED STATES, August 13, 2025 /⁨EINPresswire.com⁩/ -- Choate Hall & Stewart LLP announces that Rob Kole has been named co-managing...

Quesito El Establo Retira Del Mercado Queso (Quesito Colombiano) Debido a Posible Riesgo Para La Salud

Quesito El Establo Retira Del Mercado Queso (Quesito Colombiano) Debido a Posible Riesgo Para La Salud

COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos...

Toll Brothers Opens Enclave at Sprain Brook Luxury Townhome Community in Yonkers, New York

Toll Brothers Opens Enclave at Sprain Brook Luxury Townhome Community in Yonkers, New York

YONKERS, N.Y., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest townhome community, Enclave at Sprain Brook, is now open for sale in Yonkers, New York....

PhotoPharmics Expands Enrollment Beyond 300 in Groundbreaking Trial to Show Improvement Beyond Current Therapies

PhotoPharmics Expands Enrollment Beyond 300 in Groundbreaking Trial to Show Improvement Beyond Current Therapies

New clinical sites open in Illinois, Florida, and Arizona; trial remains open to participants across 19 states. SALT LAKE CITY, UT, UNITED STATES, August 13, 2025 /⁨EINPresswire.com⁩/ -- PhotoPharmics, the leader in specialized phototherapy for...

ProMIS Neurosciences Announces Second Quarter 2025 Financial Results & Corporate Highlights

ProMIS Neurosciences Announces Second Quarter 2025 Financial Results & Corporate Highlights

U.S. FDA Grants Fast Track Designation for PMN310 in Alzheimer’s Disease, enhancing program’s potential for priority review PRECISE-AD Phase 1b Trial in Alzheimer’s Disease Progressing on Schedule: Over 50% enrolled, no cases of ARIA and no...

Draft Season is Here: Samuel Adams Celebrates Octoberfest and Fantasy Football’s Return

Draft Season is Here: Samuel Adams Celebrates Octoberfest and Fantasy Football’s Return

Boston, MA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Samuel Adams, one of the pioneers of the craft beer movement and the brewer behind #1 best-selling fall seasonal Octoberfest [1], is gearing up for football season by honoring the real MVPs of fantasy...

Cue Biopharma Announces Initiation of Investigator Sponsored Trial of CUE-102 in Recurrent Glioblastoma Multiforme

Cue Biopharma Announces Initiation of Investigator Sponsored Trial of CUE-102 in Recurrent Glioblastoma Multiforme

First patient dosed with CUE-102 for recurrent glioblastoma multiforme (rGBM) at Dana-Farber Cancer Institute (DFCI) BOSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing...

ElevateBio BaseCamp Achieves ICMC™ Certification for Commercial Cell and Gene Therapy Manufacturing Capabilities

ElevateBio BaseCamp Achieves ICMC™ Certification for Commercial Cell and Gene Therapy Manufacturing Capabilities

ICMC certification delivered by Dark Horse Consulting certifies ElevateBio’s compliant and scalable manufacturing capabilities for advanced therapies using U.S. and E.U. commercial-level evaluation standards BaseCamp is the first genetic medicine...

X4 Pharmaceuticals Announces Closing of Upsized $85 Million Private Placement

X4 Pharmaceuticals Announces Closing of Upsized $85 Million Private Placement

BOSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today closed an upsized private placement of 11,040,776 shares of common stock...

VIVE Collision Expands to Delaware with Acquisition of Evolve

VIVE Collision Expands to Delaware with Acquisition of Evolve

VIVE Collision Expands to Delaware, Marking Entry into 10th State with EV-Focused Acquisition NEW CASTLE, DE, UNITED STATES, August 13, 2025 /⁨EINPresswire.com⁩/ -- VIVE Collision, one of the fastest-growing collision repair operators in the...

Blood-based test provides new diagnostic approach for multiple myeloma

Blood-based test provides new diagnostic approach for multiple myeloma

Researchers at Dana-Farber Cancer Institute, Massachusetts General Hospital (MGH), and the Broad Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new...

Students File Landmark Lawsuit Alleging Elite Colleges Conspired to Present Early Decision as Binding & Inflate Tuition

Students File Landmark Lawsuit Alleging Elite Colleges Conspired to Present Early Decision as Binding & Inflate Tuition

BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- An antitrust class action lawsuit filed today in the U.S. District Court for the District of Massachusetts accuses some of the nation’s most prestigious colleges and universities of participating in an...

26 Fugitives Wanted for Violent and Serious Crimes Returned to the United States from Mexico Including Leaders of Foreign Terrorist Organizations and Alien Smuggling Organization

26 Fugitives Wanted for Violent and Serious Crimes Returned to the United States from Mexico Including Leaders of Foreign Terrorist Organizations and Alien Smuggling Organization

The United States announced today that it has taken into custody 26 fugitives from Mexico facing a range of federal and state criminal charges from around the country, including charges relating to drug-trafficking, hostage-taking, kidnapping,...

Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering

Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering

BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases,...

Quesito El Establo Recalls Spanish Cheese (Quesito Colombiano) Because of Possible Health Risk

Quesito El Establo Recalls Spanish Cheese (Quesito Colombiano) Because of Possible Health Risk

COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos...

Quesito El Establo Recalls Spanish Cheese (Quesito Colombiano) Because of Possible Health Risk

Quesito El Establo Recalls Spanish Cheese (Quesito Colombiano) Because of Possible Health Risk

COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions